| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.03 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.03 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.56 | 0.04 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.04 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.11 | 0.04 |